ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,480,706 | +485.3% | 132,561 | +2615.3% | 0.04% | +311.1% |
| Q3 2022 | $253,000 | -14.5% | 4,882 | -21.9% | 0.01% | -30.8% |
| Q2 2022 | $296,000 | -15.4% | 6,252 | -21.4% | 0.01% | -56.7% |
| Q2 2021 | $350,000 | +16.7% | 7,958 | +11.7% | 0.03% | -6.2% |
| Q4 2020 | $300,000 | -58.1% | 7,124 | -54.4% | 0.03% | -30.4% |
| Q3 2020 | $716,000 | +82.2% | 15,638 | +99.6% | 0.05% | +70.4% |
| Q2 2020 | $393,000 | +21.7% | 7,836 | +104.9% | 0.03% | -6.9% |
| Q2 2019 | $323,000 | -77.5% | 3,824 | -74.5% | 0.03% | -71.6% |
| Q1 2019 | $1,433,000 | +134.9% | 15,004 | +184.9% | 0.10% | +142.9% |
| Q2 2018 | $610,000 | +20.6% | 5,266 | -38.9% | 0.04% | -25.0% |
| Q4 2017 | $506,000 | – | 8,620 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |